Stephen V Liu/X
Mar 19, 2025, 09:27
Stephen V Liu: ELCC25 program
Stephen V Liu, Associate Professor of Medicine at Georgetown University, Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center, shared a post on X:
“ELCC25 program includes OS updates from MARIPOSA and LAURA in EGFR NSCLC, adagrasib + pembrolizumab in KRAS G12C, and final analysis from KEYNOTE 799 of pembrolizumab + chemoradiation in stage III NSCLC.
Educational program highlights include AI session with Dr. Arsela Prelaj.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 5, 2025, 16:29
Aug 5, 2025, 16:07
Aug 5, 2025, 16:04
Aug 5, 2025, 14:16
Aug 5, 2025, 13:23
Aug 5, 2025, 12:52